These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36737781)

  • 1. Diagnostic approach and grading scheme for canine allergic conjunctivitis.
    Delgado E; Gomes É; Gil S; Lourenço AM
    BMC Vet Res; 2023 Feb; 19(1):35. PubMed ID: 36737781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergic conjunctivitis and conjunctival provocation tests in atopic dogs.
    Lourenço-Martins AM; Delgado E; Neto I; Peleteiro MC; Morais-Almeida M; Correia JH
    Vet Ophthalmol; 2011 Jul; 14(4):248-56. PubMed ID: 21733066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis.
    Williams JI; Kennedy KS; Gow JA; Torkildsen GL; Abelson MB; Gomes PJ; McNamara TR;
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):385-93. PubMed ID: 21649522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
    Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
    Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selected cytokine expression in dogs with alergic conjunctivitis: Correlation with disease activity.
    Varandas C; Cartaxeiro C; Lourenço AM; Delgado E; Gil S
    Res Vet Sci; 2020 Jun; 130():33-40. PubMed ID: 32114248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the topical antihistamine olopatadine in dogs with experimentally induced allergic conjunctivitis.
    Mamo ET; Newbold GM; Moorehead SC
    Vet Ophthalmol; 2023 Dec; ():. PubMed ID: 38066706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis.
    Abelson MB; Gomes P; Crampton HJ; Schiffman RM; Bradford RR; Whitcup SM
    Clin Ther; 2004 Jan; 26(1):35-47. PubMed ID: 14996516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial.
    Crampton HJ
    Clin Ther; 2003 Jul; 25(7):1975-87. PubMed ID: 12946545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated phase III trials of bepotastine besilate ophthalmic solution 1.5% for ocular itching associated with allergic conjunctivitis.
    Meier EJ; Torkildsen GL; Gow JA; McNamara TR; Gomes PJ; Williams JI;
    Allergy Asthma Proc; 2012; 33(3):265-74. PubMed ID: 22991696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the human conjunctival allergen challenge model.
    D'Arienzo PA; Leonardi A; Bensch G
    Clin Ther; 2002 Mar; 24(3):409-16. PubMed ID: 11952024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter clinical evaluation of bepotastine besilate ophthalmic solutions 1.0% and 1.5% to treat allergic conjunctivitis.
    Macejko TT; Bergmann MT; Williams JI; Gow JA; Gomes PJ; McNamara TR; Abelson MB;
    Am J Ophthalmol; 2010 Jul; 150(1):122-127.e5. PubMed ID: 20488431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of eye rubbing on signs and symptoms of allergic conjunctivitis in cat-sensitive individuals.
    Raizman MB; Rothman JS; Maroun F; Rand WM
    Ophthalmology; 2000 Dec; 107(12):2158-61. PubMed ID: 11097588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular conjunctivitis in dogs: A retrospective study (2007-2022).
    Cerrada I; Leiva M; Vilao R; Peña T; Ríos J
    Vet Ophthalmol; 2024 Jul; 27(4):310-317. PubMed ID: 37850538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis.
    Tagawa Y; Namba K; Nakazono Y; Iwata D; Ishida S
    Allergol Int; 2017 Apr; 66(2):338-343. PubMed ID: 27720602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of cytokines on ocular surfaces of atopic dogs by multiplex analysis using two sampling methods - a pilot study.
    Pressanti C; Ravailhe E; Castellote-Brun J; Amalric N; Lecru LA; Kondratjeva J; Moog F; Combarros D; Douet JY; Cadiergues MC
    Vet Dermatol; 2021 Dec; 32(6):625-e167. PubMed ID: 34390059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of pruritus in canine atopic dermatitis, flea bite hypersensitivity and flea infestation and its role in diagnosis.
    Bruet V; Bourdeau PJ; Roussel A; Imparato L; Desfontis JC
    Vet Dermatol; 2012 Dec; 23(6):487-e93. PubMed ID: 23013416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular itch relief with alcaftadine 0.25% versus olopatadine 0.2% in allergic conjunctivitis: pooled analysis of two multicenter randomized clinical trials.
    McLaurin EB; Marsico NP; Ackerman SL; Ciolino JB; Williams JM; Villanueva L; Hollander DA
    Adv Ther; 2014 Oct; 31(10):1059-71. PubMed ID: 25260889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjunctivitis and rhinoconjunctivitis.
    Abelson MB; Turner D
    Clin Ther; 2003 Mar; 25(3):931-47. PubMed ID: 12852709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsteroidal management of canine pruritus with amitriptyline.
    Miller WH; Scott DW; Wellington JR
    Cornell Vet; 1992 Jan; 82(1):53-7. PubMed ID: 1740060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
    Spangler DL; Abelson MB; Ober A; Gotnes PJ
    Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.